Marimed (MRMD) EBT (2011 - 2026)

Marimed (MRMD) has reported EBT for 16 consecutive years, with -$1.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBT fell 120.6% year-over-year to -$1.6 million in Q2 2026; TTM through Jun 2026 was -$10.2 million, a 45.35% decrease from a year earlier, with the FY2025 full-year figure at -$10.9 million, down 154.32% from the prior year.
• EBT was -$1.6 million for Q2 2026 at Marimed, down from -$1.1 million in the prior quarter.
• Over five years, EBT peaked at $7.9 million in Q1 2022 and troughed at -$9.6 million in Q4 2023.
• A 5-year average of -$258055.6 and a median of -$258500.0 in 2024 frame the typical range for EBT.
• Across the five-year window, EBT soared 258.72% in 2022 and sank 765.33% in 2025, its largest moves.
• Over 5 years, EBT stood at $2.8 million in 2022, then tumbled by 449.55% to -$9.6 million in 2023, then soared by 65.57% to -$3.3 million in 2024, then tumbled by 120.99% to -$7.3 million in 2025, then soared by 78.81% to -$1.6 million in 2026.
• The last three EBT figures came in at -$1.6 million (Q2 2026), -$1.1 million (Q1 2026), and -$7.3 million (Q4 2025), per Business Quant data.